Satellos Bioscience Inc. (MSLE) Ownership
MSLE ownership summary
as of October 18, 2026- Institutions
- 49.7% of shares outstanding
- Insiders
- 6.37% of shares outstanding
- Shares outstanding
- 21.2M
- Float
- 18.0M shares available to trade
- Short interest
- — 106K shares short
- Days to cover
- 1.97 short interest up 28.2% vs prior month
- Institutions 49.70%
- Insiders 6.37%
- Other investors 43.93%
MSLE top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Franklin Templeton Inc | 4.42% | 939K | $6.1M | — | June 30, 2026 |
| 2 | Siren, L.L.C. | 4.20% | 892K | $5.8M | — | June 30, 2026 |
| 3 | Vivo Capital, LLC | 3.84% | 814K | $5.3M | — | June 30, 2026 |
| 4 | Point72 Asset Management, L.P. | 3.22% | 683K | $4.4M | −8,078 (−1.2%) | June 30, 2026 |
| 5 | Sphera Funds Management Ltd. | 3.08% | 653K | $4.2M | +163,383 (+33.4%) | June 30, 2026 |
| 6 | Woodline Partners LP | 2.36% | 500K | $3.2M | — | June 30, 2026 |
| 7 | Stonepine Capital Management Llc | 2.32% | 492K | $3.2M | +391,624 (+391.6%) | June 30, 2026 |
| 8 | Suvretta Capital Management, LLC | 2.24% | 475K | $3.1M | — | June 30, 2026 |
| 9 | Avidity Partners Management LP | 1.83% | 388K | $2.5M | −387,769 (−50.0%) | June 30, 2026 |
| 10 | Saturn V Capital Management LLC | 1.65% | 350K | $2.3M | — | June 30, 2026 |
| 11 | Soleus Capital Management, L.P. | 1.48% | 314K | $2.0M | −100,000 (−24.1%) | June 30, 2026 |
| 12 | 683 Capital Management LLC | 1.09% | 231K | $1.5M | +230,833 (0.0%) | March 31, 2026 |
| 13 | ADAR1 Capital Management LLC | 1.05% | 223K | $1.4M | — | June 30, 2026 |
| 14 | Awm Investment Company Inc | 0.85% | 180K | $1.2M | +180,000 (0.0%) | June 30, 2026 |
| 15 | Millennium Management LLC | 0.72% | 153K | $986,881 | −145,665 (−48.8%) | June 30, 2026 |
| 16 | Adage Capital Partners Gp LLC | 0.71% | 150K | $969,000 | −230,354 (−60.6%) | June 30, 2026 |
| 17 | Empery Asset Management, LP | 0.50% | 107K | $691,866 | −123,000 (−53.5%) | June 30, 2026 |
| 18 | Citadel Advisors Llc | 0.32% | 68K | $437,587 | +25,246 (+59.4%) | June 30, 2026 |
| 19 | Morgan Stanley - Brokerage Accounts | 0.12% | 26K | $166,229 | +4,549 (+21.5%) | June 30, 2026 |
| 20 | China Universal Asset Mgmt Co.Ltd | 0.09% | 20K | $129,200 | +13,600 (+212.5%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 7 holders added 1.0M shares and 6 cut 995K.
MSLE top mutual fund and ETF holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Franklin Biotechnology Discv A(acc)USD | 2.81% | 595K | $3.8M | — | August 31, 2026 |
| 2 | Franklin Biotechnology Discovery A | 1.62% | 343K | $2.2M | — | August 31, 2026 |
| 3 | China Universal Gbl YLBJ QDII CNH | 0.09% | 20K | $129,200 | +20,000 (0.0%) | June 30, 2026 |
| 4 | Fidelity Nasdaq Composite Index | 0.06% | 13K | $84,116 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
MSLE shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns MSLE
Institutional investors own 49.7% of Satellos Bioscience's shares and insiders 6.37%. The largest holder is Franklin Templeton Inc with 4.42% of the shares (939K), as of June 30, 2026. Among the top 20 institutions, 7 added shares and 6 reduced their stake in the latest filings. The share count rose 4,293.0% since 2017.
Related: MSLE analyst forecast, MSLE key metrics. See the MSLE stock overview for the latest quote and news.
MSLE ownership FAQ
Who owns the most Satellos Bioscience stock?
The largest shareholders of Satellos Bioscience are Franklin Templeton Inc (4.42%), Siren, L.L.C. (4.20%), Vivo Capital, LLC (3.84%), Point72 Asset Management, L.P. (3.22%), Sphera Funds Management Ltd. (3.08%).
What percentage of Satellos Bioscience is owned by institutions?
Institutions hold 49.7% of Satellos Bioscience's shares outstanding; insiders hold 6.37%.
Which funds own Satellos Bioscience?
The largest fund holders of Satellos Bioscience are Franklin Biotechnology Discv A(acc)USD (2.81%), Franklin Biotechnology Discovery A (1.62%), China Universal Gbl YLBJ QDII CNH (0.09%), Fidelity Nasdaq Composite Index (0.06%).
How many shares of Satellos Bioscience are outstanding?
Satellos Bioscience has 21.2M shares outstanding, of which 18.0M are in the public float.